Matches in SemOpenAlex for { <https://semopenalex.org/work/W2959936147> ?p ?o ?g. }
- W2959936147 endingPage "951" @default.
- W2959936147 startingPage "944" @default.
- W2959936147 abstract "Objective Our objective was to determine whether attention-deficit/hyperactivity disorder (ADHD) medication is associated with a decreased risk of unintentional injuries in children and adolescents in the United States across sexes, age groups and injury types. Method We used de-identified inpatient, outpatient, and filled prescription claims data from the Truven Health MarketScan Research Databases. Individuals were followed from January 1, 2005, date of first ADHD diagnosis, or medication prescription, or age 6 years, whichever occurred last, until December 31, 2014, first healthcare insurance disenrollment, or the first year at which their age was recorded as 19 years, whichever occurred first. A person was considered on ADHD medication during a given month if a prescription was filled in that month. The outcome was defined as emergency department visits for injuries, including traumatic brain injuries, with unintentional causes. Odds of having the outcome were compared between medicated and unmedicated months at the population-level and in within-individual analyses using logistic regression. Results Among 1,968,146 individuals diagnosed with ADHD or receiving ADHD medication, 87,154 had at least one event. At the population level, medication use was associated with a lower risk of injuries, both in boys (odds ratio [OR] = 0.85; 95% CI = 0.84−0.86) and girls (OR = 0.87; 95% CI = 0.85−0.89). Similar results were obtained from within-individual analysis among male (OR = 0.72; 95% CI = 0.70−0.74) and female (OR = 0.72; 95% CI = 0.69−0.75) children, and among male (OR = 0.64; 95% CI = 0.60−0.67) and female (OR = 0.65; 95% CI = 0.60−0.71) adolescents. Similar results were found for traumatic brain injuries. Conclusion ADHD medication use was associated with a reduction of different types of unintentional injuries in children and adolescents of both sexes. Our objective was to determine whether attention-deficit/hyperactivity disorder (ADHD) medication is associated with a decreased risk of unintentional injuries in children and adolescents in the United States across sexes, age groups and injury types. We used de-identified inpatient, outpatient, and filled prescription claims data from the Truven Health MarketScan Research Databases. Individuals were followed from January 1, 2005, date of first ADHD diagnosis, or medication prescription, or age 6 years, whichever occurred last, until December 31, 2014, first healthcare insurance disenrollment, or the first year at which their age was recorded as 19 years, whichever occurred first. A person was considered on ADHD medication during a given month if a prescription was filled in that month. The outcome was defined as emergency department visits for injuries, including traumatic brain injuries, with unintentional causes. Odds of having the outcome were compared between medicated and unmedicated months at the population-level and in within-individual analyses using logistic regression. Among 1,968,146 individuals diagnosed with ADHD or receiving ADHD medication, 87,154 had at least one event. At the population level, medication use was associated with a lower risk of injuries, both in boys (odds ratio [OR] = 0.85; 95% CI = 0.84−0.86) and girls (OR = 0.87; 95% CI = 0.85−0.89). Similar results were obtained from within-individual analysis among male (OR = 0.72; 95% CI = 0.70−0.74) and female (OR = 0.72; 95% CI = 0.69−0.75) children, and among male (OR = 0.64; 95% CI = 0.60−0.67) and female (OR = 0.65; 95% CI = 0.60−0.71) adolescents. Similar results were found for traumatic brain injuries. ADHD medication use was associated with a reduction of different types of unintentional injuries in children and adolescents of both sexes." @default.
- W2959936147 created "2019-07-23" @default.
- W2959936147 creator A5014708668 @default.
- W2959936147 creator A5014856006 @default.
- W2959936147 creator A5021664662 @default.
- W2959936147 creator A5030674909 @default.
- W2959936147 creator A5039656137 @default.
- W2959936147 creator A5040487176 @default.
- W2959936147 creator A5057258523 @default.
- W2959936147 creator A5083088232 @default.
- W2959936147 date "2020-08-01" @default.
- W2959936147 modified "2023-10-13" @default.
- W2959936147 title "Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents" @default.
- W2959936147 cites W1608645544 @default.
- W2959936147 cites W1963103916 @default.
- W2959936147 cites W1990514899 @default.
- W2959936147 cites W2009355338 @default.
- W2959936147 cites W2009766215 @default.
- W2959936147 cites W2021181793 @default.
- W2959936147 cites W2034264179 @default.
- W2959936147 cites W2034961427 @default.
- W2959936147 cites W2081628621 @default.
- W2959936147 cites W2099805984 @default.
- W2959936147 cites W2101290999 @default.
- W2959936147 cites W2101805186 @default.
- W2959936147 cites W2103408528 @default.
- W2959936147 cites W2120831849 @default.
- W2959936147 cites W2127901933 @default.
- W2959936147 cites W2155681415 @default.
- W2959936147 cites W2170219130 @default.
- W2959936147 cites W2517533671 @default.
- W2959936147 cites W2519433651 @default.
- W2959936147 cites W2548550313 @default.
- W2959936147 cites W2597501992 @default.
- W2959936147 cites W2613325482 @default.
- W2959936147 cites W2728417648 @default.
- W2959936147 cites W2766710253 @default.
- W2959936147 cites W2769961275 @default.
- W2959936147 cites W2775598075 @default.
- W2959936147 cites W2889542606 @default.
- W2959936147 cites W2890361884 @default.
- W2959936147 doi "https://doi.org/10.1016/j.jaac.2019.06.010" @default.
- W2959936147 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6954332" @default.
- W2959936147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31302218" @default.
- W2959936147 hasPublicationYear "2020" @default.
- W2959936147 type Work @default.
- W2959936147 sameAs 2959936147 @default.
- W2959936147 citedByCount "21" @default.
- W2959936147 countsByYear W29599361472019 @default.
- W2959936147 countsByYear W29599361472020 @default.
- W2959936147 countsByYear W29599361472021 @default.
- W2959936147 countsByYear W29599361472022 @default.
- W2959936147 countsByYear W29599361472023 @default.
- W2959936147 crossrefType "journal-article" @default.
- W2959936147 hasAuthorship W2959936147A5014708668 @default.
- W2959936147 hasAuthorship W2959936147A5014856006 @default.
- W2959936147 hasAuthorship W2959936147A5021664662 @default.
- W2959936147 hasAuthorship W2959936147A5030674909 @default.
- W2959936147 hasAuthorship W2959936147A5039656137 @default.
- W2959936147 hasAuthorship W2959936147A5040487176 @default.
- W2959936147 hasAuthorship W2959936147A5057258523 @default.
- W2959936147 hasAuthorship W2959936147A5083088232 @default.
- W2959936147 hasBestOaLocation W29599361472 @default.
- W2959936147 hasConcept C118552586 @default.
- W2959936147 hasConcept C126322002 @default.
- W2959936147 hasConcept C142724271 @default.
- W2959936147 hasConcept C151956035 @default.
- W2959936147 hasConcept C156957248 @default.
- W2959936147 hasConcept C187155963 @default.
- W2959936147 hasConcept C187212893 @default.
- W2959936147 hasConcept C190385971 @default.
- W2959936147 hasConcept C194828623 @default.
- W2959936147 hasConcept C2426938 @default.
- W2959936147 hasConcept C2780724011 @default.
- W2959936147 hasConcept C2780783007 @default.
- W2959936147 hasConcept C2908647359 @default.
- W2959936147 hasConcept C3017944768 @default.
- W2959936147 hasConcept C71924100 @default.
- W2959936147 hasConcept C98274493 @default.
- W2959936147 hasConcept C99454951 @default.
- W2959936147 hasConceptScore W2959936147C118552586 @default.
- W2959936147 hasConceptScore W2959936147C126322002 @default.
- W2959936147 hasConceptScore W2959936147C142724271 @default.
- W2959936147 hasConceptScore W2959936147C151956035 @default.
- W2959936147 hasConceptScore W2959936147C156957248 @default.
- W2959936147 hasConceptScore W2959936147C187155963 @default.
- W2959936147 hasConceptScore W2959936147C187212893 @default.
- W2959936147 hasConceptScore W2959936147C190385971 @default.
- W2959936147 hasConceptScore W2959936147C194828623 @default.
- W2959936147 hasConceptScore W2959936147C2426938 @default.
- W2959936147 hasConceptScore W2959936147C2780724011 @default.
- W2959936147 hasConceptScore W2959936147C2780783007 @default.
- W2959936147 hasConceptScore W2959936147C2908647359 @default.
- W2959936147 hasConceptScore W2959936147C3017944768 @default.
- W2959936147 hasConceptScore W2959936147C71924100 @default.
- W2959936147 hasConceptScore W2959936147C98274493 @default.
- W2959936147 hasConceptScore W2959936147C99454951 @default.
- W2959936147 hasFunder F4320306098 @default.